Literature DB >> 28449072

Functions of galectins as 'self/non-self'-recognition and effector factors.

Gerardo R Vasta1, Chiguang Feng1, Nuria González-Montalbán1, Justin Mancini1, Lishi Yang1, Kelsey Abernathy1, Graeme Frost1, Cheyenne Palm1.   

Abstract

Carbohydrate structures on the cell surface encode complex information that through specific recognition by carbohydrate-binding proteins (lectins) modulates interactions between cells, cells and the extracellular matrix, or mediates recognition of potential microbial pathogens. Galectins are a family of ß-galactoside-binding lectins, which are evolutionary conserved and have been identified in most organisms, from fungi to invertebrates and vertebrates, including mammals. Since their discovery in the 1970s, their biological roles, initially understood as limited to recognition of endogenous carbohydrate ligands in embryogenesis and development, have expanded in recent years by the discovery of their roles in tissue repair and regulation of immune homeostasis. More recently, evidence has accumulated to support the notion that galectins can also bind glycans on the surface of potentially pathogenic microbes, and function as recognition and effector factors in innate immunity, thus establishing a new paradigm. Furthermore, some parasites 'subvert' the recognition roles of the vector/host galectins for successful attachment or invasion. These recent findings have revealed a striking functional diversification in this structurally conserved lectin family. © FEMS 2017. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  carbohydrate recognition domain: glycans; chimera; function; galectins, ß-galactoside; pattern recognition receptors; proto-type; structure; tandem repeat

Mesh:

Substances:

Year:  2017        PMID: 28449072      PMCID: PMC5808656          DOI: 10.1093/femspd/ftx046

Source DB:  PubMed          Journal:  Pathog Dis        ISSN: 2049-632X            Impact factor:   3.166


  82 in total

Review 1.  Clusters, bundles, arrays and lattices: novel mechanisms for lectin-saccharide-mediated cellular interactions.

Authors:  C Fred Brewer; M Carrie Miceli; Linda G Baum
Journal:  Curr Opin Struct Biol       Date:  2002-10       Impact factor: 6.809

2.  Genomic analysis of immunity in a Urochordate and the emergence of the vertebrate immune system: "waiting for Godot".

Authors:  Kaoru Azumi; Rosaria De Santis; Anthony De Tomaso; Isidore Rigoutsos; Fumiko Yoshizaki; Maria Rosaria Pinto; Rita Marino; Kazuhito Shida; Makoto Ikeda; Masami Ikeda; Masafumi Arai; Yasuhito Inoue; Toshio Shimizu; Nori Satoh; Daniel S Rokhsar; Louis Du Pasquier; Masanori Kasahara; Masanobu Satake; Masaru Nonaka
Journal:  Immunogenetics       Date:  2003-10-07       Impact factor: 2.846

Review 3.  Re-wiring regulatory cell networks in immunity by galectin-glycan interactions.

Authors:  Ada G Blidner; Santiago P Méndez-Huergo; Alejandro J Cagnoni; Gabriel A Rabinovich
Journal:  FEBS Lett       Date:  2015-09-06       Impact factor: 4.124

Review 4.  Biological roles of lectins in innate immunity: molecular and structural basis for diversity in self/non-self recognition.

Authors:  Gerardo R Vasta; Hafiz Ahmed; Satoshi Tasumi; Eric W Odom; Keiko Saito
Journal:  Adv Exp Med Biol       Date:  2007       Impact factor: 2.622

5.  Characterization of a binary tandem domain F-type lectin from striped bass (Morone saxatilis).

Authors:  Eric W Odom; Gerardo R Vasta
Journal:  J Biol Chem       Date:  2005-10-26       Impact factor: 5.157

6.  Uncoupling of chondrocyte death and vascular invasion in mouse galectin 3 null mutant bones.

Authors:  C Colnot; S S Sidhu; N Balmain; F Poirier
Journal:  Dev Biol       Date:  2001-01-01       Impact factor: 3.582

Review 7.  Galectin-3 and heart failure: prognosis, prediction & clinical utility.

Authors:  Mando D Filipe; Wouter C Meijers; A Rogier van der Velde; Rudolf A de Boer
Journal:  Clin Chim Acta       Date:  2014-10-18       Impact factor: 3.786

8.  Glycosylation-dependent lectin-receptor interactions preserve angiogenesis in anti-VEGF refractory tumors.

Authors:  Diego O Croci; Juan P Cerliani; Tomas Dalotto-Moreno; Santiago P Méndez-Huergo; Ivan D Mascanfroni; Sebastián Dergan-Dylon; Marta A Toscano; Julio J Caramelo; Juan J García-Vallejo; Jing Ouyang; Enrique A Mesri; Melissa R Junttila; Carlos Bais; Margaret A Shipp; Mariana Salatino; Gabriel A Rabinovich
Journal:  Cell       Date:  2014-02-13       Impact factor: 41.582

Review 9.  The bitter side of sweet: the role of Galectin-9 in immunopathogenesis of viral infections.

Authors:  Shahzma Merani; Wenna Chen; Shokrollah Elahi
Journal:  Rev Med Virol       Date:  2015-03-11       Impact factor: 6.989

10.  X-ray crystal structure of the human dimeric S-Lac lectin, L-14-II, in complex with lactose at 2.9-A resolution.

Authors:  Y D Lobsanov; M A Gitt; H Leffler; S H Barondes; J M Rini
Journal:  J Biol Chem       Date:  1993-12-25       Impact factor: 5.157

View more
  13 in total

1.  GALECTIN-8 Is a Neuroprotective Factor in the Brain that Can Be Neutralized by Human Autoantibodies.

Authors:  Evelyn Pardo; Francisca Barake; Juan A Godoy; Claudia Oyanadel; Sofía Espinoza; Claudia Metz; Claudio Retamal; Loreto Massardo; Cheril Tapia-Rojas; Nibaldo C Inestrosa; Andrea Soza; Alfonso González
Journal:  Mol Neurobiol       Date:  2019-05-22       Impact factor: 5.590

2.  Galectin-3 Coordinates a Cellular System for Lysosomal Repair and Removal.

Authors:  Jingyue Jia; Aurore Claude-Taupin; Yuexi Gu; Seong Won Choi; Ryan Peters; Bhawana Bissa; Michal H Mudd; Lee Allers; Sandeep Pallikkuth; Keith A Lidke; Michelle Salemi; Brett Phinney; Muriel Mari; Fulvio Reggiori; Vojo Deretic
Journal:  Dev Cell       Date:  2019-12-05       Impact factor: 12.270

3.  The lectin Discoidin I acts in the cytoplasm to help assemble the contractile machinery.

Authors:  Ly T S Nguyen; Douglas N Robinson
Journal:  J Cell Biol       Date:  2022-09-27       Impact factor: 8.077

4.  Galectin-1 interacts with the human endogenous retroviral envelope protein syncytin-2 and potentiates trophoblast fusion in humans.

Authors:  Caroline Toudic; Amandine Vargas; Yong Xiao; Guillaume St-Pierre; Norbert Bannert; Julie Lafond; Éric Rassart; Sachiko Sato; Benoit Barbeau
Journal:  FASEB J       Date:  2019-09-07       Impact factor: 5.191

5.  Proteomic identification of galectin-11 and 14 ligands from Haemonchus contortus.

Authors:  Dhanasekaran Sakthivel; Jaclyn Swan; Sarah Preston; M D Shakif-Azam; Pierre Faou; Yaqing Jiao; Rachael Downs; Harinda Rajapaksha; Robin Gasser; David Piedrafita; Travis Beddoe
Journal:  PeerJ       Date:  2018-03-19       Impact factor: 2.984

Review 6.  Glycans as Key Checkpoints of T Cell Activity and Function.

Authors:  Márcia S Pereira; Inês Alves; Manuel Vicente; Ana Campar; Mariana C Silva; Nuno A Padrão; Vanda Pinto; Ângela Fernandes; Ana M Dias; Salomé S Pinho
Journal:  Front Immunol       Date:  2018-11-27       Impact factor: 7.561

7.  Human-like NSG mouse glycoproteins sialylation pattern changes the phenotype of human lymphocytes and sensitivity to HIV-1 infection.

Authors:  Raghubendra Singh Dagur; Amanda Branch-Woods; Saumi Mathews; Poonam S Joshi; Rolen M Quadros; Donald W Harms; Yan Cheng; Shana M Miles; Samuel J Pirruccello; Channabasavaiah B Gurumurthy; Santhi Gorantla; Larisa Y Poluektova
Journal:  BMC Immunol       Date:  2019-01-07       Impact factor: 3.615

Review 8.  Immunopathology of Recurrent Vulvovaginal Infections: New Aspects and Research Directions.

Authors:  Namarta Kalia; Jatinder Singh; Manpreet Kaur
Journal:  Front Immunol       Date:  2019-08-28       Impact factor: 7.561

Review 9.  Role of galectin-glycan circuits in reproduction: from healthy pregnancy to preterm birth (PTB).

Authors:  Sandra M Blois; Stefan Verlohren; Gang Wu; Gary Clark; Anne Dell; Stuart M Haslam; Gabriela Barrientos
Journal:  Semin Immunopathol       Date:  2020-06-29       Impact factor: 9.623

Review 10.  Targeting the glycans: A paradigm for host-targeted and COVID-19 drug design.

Authors:  Fatemeh Pourrajab
Journal:  J Cell Mol Med       Date:  2021-05-24       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.